Log in to save to my catalogue

Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin ef...

Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin ef...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1f5177ae512441ffab056e955c214925

Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin effects

About this item

Full title

Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin effects

Publisher

United States: John Wiley & Sons, Inc

Journal title

Cancer medicine (Malden, MA), 2022-10, Vol.11 (20), p.3820-3836

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Backgorund
Prior data suggest pre‐diagnostic aspirin use impacts breast tumour biology and patient outcome. Here, we employed faithful surgical resection models of HER2+ and triple‐negative breast cancer (TNBC), to study outcome and response mechanisms across breast cancer subtypes.
Method
NOD/SCID mice were implanted with HER2+ MDA‐MB‐231...

Alternative Titles

Full title

Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin effects

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1f5177ae512441ffab056e955c214925

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1f5177ae512441ffab056e955c214925

Other Identifiers

ISSN

2045-7634

E-ISSN

2045-7634

DOI

10.1002/cam4.4756

How to access this item